Ocrevus®
Ocrevus® (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells. This may help to protect healthy cells from damage. Specifically it is a CD20-cytolytic antibody for the treatment of Multiple Sclerosis (MS).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Genentech |
CLASS: Biologics (CD20 cytolytic antibodies) |
PRESCRIBED BY: Neurologists |
HOW ADMINISTERED: IV infusion |
FREQUENCY: Once every six months |
Length of infusion: At least three hours |
FOR MORE INFORMATION: |
